Late-breaking Analysis From the remedē® System Pivotal Trial Suggests Favorable Outcomes for Heart Failure (HF) Patients With Central Sleep Apnea Receiving Phrenic Nerve Stimulation

Analysis conducted on a hierarchical endpoint comprised of mortality, HF hospitalization, and health status shows that patients treated with phrenic nerve stimulation may be nearly five times as likely to experience a clinical benefit compared to those in the control group

Matt Hogan ZOLL Medical Corporation +1 (978) 805-6561 [email protected]